Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Miller-Fisher syndrome

Charcot- Marie ibolli type 1A Botulism, cisplatin neuropathy Miller-Fisher syndrome... [Pg.621]

Miller-Fisher syndrome, Bickerstaff s brainstem encephalitis Acute motor axonal neuropathy Immunoglobulin light-chain amyloid neuropathy Cryoglobulinemic neuropathy... [Pg.622]

Neisser, A., Bemheimer, H., Berger, T., Moran, A.P., Schwerer, B. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun 65 (1997) 4038 1042. [Pg.237]

Willison, H.J., Veitch, J. Immunoglobulin subclass distribution and binding characteristics of anti-GQm antibodies in Miller Fisher syndrome. J Neuroimmunol 50 (1994) 159-165. [Pg.240]

Cher LM, Merory JM (1993) Miller Fisher syndrome mimicking stroke in immunosuppressed patient with rheumatoid arthritis responding to plasma exchange. J Clin Neurooph-thalmol 13 138-140... [Pg.290]

Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meche EG, Van Doom PA (2001a) Guillain-Barre syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipo-polysacchaiides induce anti-GMl and anti-GQlb antibodies in rabbits, hrfectlmmun 69 2462—2469. [Pg.275]

Buchwald B, Weishaupt A, Toyka KV, Dudel J (1998) Pre- and post-synapdc blockade of neuromuscular ti ansmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Fur J Neurosci 10 281-290. [Pg.276]

Chiba A, Kusimoki S, Shimizu T, Kanazawa I (1992) Serum IgG andbody to ganglioside GQlb is a possible marker of Miller Fisher syndrome. Ann Neurol 31 677—679. [Pg.276]

Chiba A, Kusimoki S, Obata H, Machiriami R, Kanazawa I (1993) Serum and-GQlb IgG andbody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Ban e syndrome Clinical and immimohistochemical studies. Neurology 43 1911—1917. [Pg.276]

Jacobs BC, Endtz H, van der Meche FGA, Hazeiiberg MP, Achter-eekte HA, Van Doom PA (1995) Serum and-GQlb IgG andbodies recognize surface epitopes on Campylobacter jejuni from padents widi Miller Fisher syndrome. Ann Neurol 37 260—264. [Pg.278]

Jacobs BC, Hazeiiberg MP, Van Doom PA, Endtz HPh, van der Meche FGA (1997) Cross-reacdve andbodies against gangliosides and Campylobacter jejuni lipopolysacchaiides in padents widi Guillain-BaiTe or Miller Fisher syndrome. J Eif Dis 175 729—733. [Pg.278]

Rees JH, Vaughan RW, Kondeatis E, Hughes RAC (1995b) HLA-class n alleles in Guillain-Barre syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 62 53—57. [Pg.279]

WiUison HJ, Veitch J, Patterson G, Kennedy PGE (1993) Miller Fisher syndrome is associated with serum antibodies to GQlb gangfioside. J Neurol Neurosurg Psychiatry 56 204-206. [Pg.280]

Clinicians most often confuse botulism with a polyradiculoneuropathy, such as Guillain-Barre or Miller Fisher syndrome, myasthenia gravis or central nervous system disease (36) (see Table 2.14). In the United States, a cluster of cases of flaccid paralysis is more likely secondary to botulism than to GuiUain-Barre syndrome or polio. In addition, compared to other causes of flaccid paralysis, unique features of botulism include (36) ... [Pg.73]

Fisher syndrome has been associated with previous C. jejuni infection. In Miller Fisher syndrome, antibodies to the ganglioside GQlb have been shown to produce neuromuscular block and may in part explain the clinical signs of that disorder (Willison Yuki, 2002). [Pg.57]

Peripheral neuropathies, autoimmune. Acute or chronic inflammatory neuropathies leading to demyelination and axonal damage of nerves and nerve roots associated with high-titred autoantibodies against gangliosides (e.g. Guillain-Barre syndrome, Miller-Fisher syndrome, acute sensory ataxic neuropathy). [Pg.248]

Nervous system Miller-Fisher syndrome been reported in a patient with rheumatoid arthritis taking adalimumab [96 ]. Bilateral... [Pg.780]

Kurmann P, Van Linthoudt D, So A. Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab. Clin Rheumatol 2009 28(1) 93-4. [Pg.800]

Ghiba A, Kusunoki S, Obata H, Machinami R, Kanazawa 1. GangUoside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997 745(l-2) 32-36. Fantini J, Yahi N. Molecular basis for the glycosphingoUpid-binding specificity of alpha-synuclein key role of tyrosine 39 in membrane insertion. ] Mol Biol. 2011 408(4) 654-669. [Pg.81]


See other pages where Miller-Fisher syndrome is mentioned: [Pg.622]    [Pg.622]    [Pg.210]    [Pg.227]    [Pg.289]    [Pg.276]    [Pg.4]    [Pg.257]    [Pg.8]    [Pg.49]    [Pg.56]    [Pg.357]   
See also in sourсe #XX -- [ Pg.289 ]

See also in sourсe #XX -- [ Pg.257 , Pg.263 , Pg.264 ]

See also in sourсe #XX -- [ Pg.257 , Pg.263 , Pg.264 ]




SEARCH



Fisher 1

Fisher syndrome

Miller

© 2024 chempedia.info